Atorvastatin as a promising anticryptococcal agent

Bone Marrow-Derived Macrophages (BMM): Isolation and ApplicationsPreprint

Weischenfeldt, J., & Porse, B. T. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5080 · Cited by 959 · see citing works

Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans

Zaragoza, Ó., Rodrigues, M. L., Jesus, M. D., Frasés, S., Dadachova, E., & Casadevall, A. (2009) · Advances in applied microbiology · doi:10.1016/s0065-2164(09)01204-0 · Cited by 458 · see citing works

Untitled work

(2014) · doi:10.1128/cmr.00126-13 · Cited by 437 · see citing works

An insight into the antifungal pipeline: selected new molecules and beyond

Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432 · see citing works

Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs

Rollini, M. M. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-0932-9 · Cited by 410 · see citing works

Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box

Kronstad, J. W., Attarian, R., Cadieux, B., Choi, J., D’Souza, C. A., Griffiths, E., Geddes, J. M. H., Hu, G., Jung, W. H., Kretschmer, M., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2522 · Cited by 340 · see citing works

Global Molecular Epidemiology ofCryptococcus neoformansandCryptococcus gattii: An Atlas of the Molecular Types

Cogliati, M. (2013) · Scientifica · doi:10.1155/2013/675213 · Cited by 273 · see citing works

Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections

Dalli, J., Chiang, N., & Serhan, C. N. (2015) · Nature Medicine · doi:10.1038/nm.3911 · Cited by 249 · see citing works

The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

Zhai, B., Wu, C., Wang, L., Sachs, M. S., & Lin, X. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00212-12 · Cited by 205 · see citing works

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: An open-label dose-ranging study

Rhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00074-8 · Cited by 183 · see citing works

Preadmission Use of Statins and Outcomes After Hospitalization With Pneumonia

Thomsen, R. W., Riis, A. H., Kornum, J. B., Christensen, S., Johnsen, S. P., & Sørensen, H. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2081 · Cited by 171 · see citing works

Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations

Nimrichter, L., Frasés, S., Cinelli, L. P., Viana, N. B., Nakouzi, A. S., Travassos, L. R., Casadevall, A., & Rodrigues, M. L. (2007) · Eukaryotic Cell · doi:10.1128/ec.00122-07 · Cited by 144 · see citing works

Growth inhibition of<i>Candida</i>species and<i>Aspergillus fumigatus</i>by statins

Macreadie, I. G., Johnson, G., Schlosser, T., & Macreadie, P. I. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00370.x · Cited by 136 · see citing works

Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265

Sorrell, T. C., Juillard, P.-G., Djordjevic, J. T., Kaufman-Francis, K., Dietmann, A., Milonig, A., Combes, V., & Grau, G. E. R. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2015.08.017 · Cited by 113 · see citing works

Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae

Lorenz, R. T., & Parks, L. W. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1660 · Cited by 104 · see citing works

Advancing the Drug Discovery and Development Process

Nicolaou, K. C. (2014) · Angewandte Chemie · doi:10.1002/ange.201404761 · Cited by 102 · see citing works

The Impact of the Host on Fungal Infections

Perfect, J. R. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.010 · Cited by 100 · see citing works

A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis

Butts, A., DiDone, L., Koselny, K., Baxter, B. K., Chabrier-Rosello, Y., Wellington, M., & Krysan, D. J. (2013) · Eukaryotic Cell · doi:10.1128/ec.00314-12 · Cited by 95 · see citing works

Advancing the Drug Discovery and Development Process

Nicolaou, K. C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404761 · Cited by 94 · see citing works

Characterization of a Novel, Broad-Based Fungicidal Activity for the Antiarrhythmic Drug Amiodarone

Courchesne, W. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.195 · Cited by 94 · see citing works

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi: Synergistic interactions between statins and azoles

Nyilasi, I., Kocsubé, S., Krizsán, K., Galgóczy, L., Pesti, M., Papp, T., & Vágvölgyi, C. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01972.x · Cited by 83 · see citing works

Immunomodulatory Effects of Serotype B Glucuronoxylomannan from Cryptococcus gattii Correlate with Polysaccharide Diameter

Fonseca, F. L., Nohara, L. L., Cordero, R. J. B., Frasés, S., Casadevall, A., de Almeida, I. C., Nimrichter, L., & Rodrigues, M. L. (2010) · Infection and Immunity · doi:10.1128/iai.00111-10 · Cited by 81 · see citing works

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms

Delattin, N., Brucker, K. D., Vandamme, K., Meert, E. M. K., Marchand, A., Chaltin, P., Cammue, B. P. A., & Thevissen, K. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt449 · Cited by 80 · see citing works

Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells

Araújo, G. R. D. S., Fonseca, F. L., Pontes, B., Torres, A., Cordero, R. J. B., Zancopé‐Oliveira, R. M., Casadevall, A., Viana, N. B., Nimrichter, L., Rodrigues, M. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029561 · Cited by 69 · see citing works

Risk of pneumonia in patients taking statins: population-based nested case-control study

Vinogradova, Y., Coupland, C. A. C., & Hippisley‐Cox, J. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x606654 · Cited by 64 · see citing works

Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs

Ogundeji, A. O., Pohl, C. H., & Sebolai, O. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02810-15 · Cited by 63 · see citing works

Dynamic Interaction between Fluconazole and Amphotericin B against Cryptococcus gattii

dos Santos, J. R. A., Gouveia, L. F., Taylor, E. L. S., de Resende, M. A., Pianetti, G. A., César, I. C., & Santos, D. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06098-11 · Cited by 62 · see citing works

Synergistic antifungal activity of statin–azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification

Cabral, M. E., Figueroa, L. I. C., & Fariña, J. I. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.09.006 · Cited by 54 · see citing works

Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis

dos Santos, J. R. A., Holanda, R. A., Frasés, S., Bravim, M., Araújo, G. R. D. S., Santos, P. C., da Costa, M. C., Ribeiro, M. J. A., Ferreira, G. F., Baltazar, L. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112669 · Cited by 46 · see citing works

Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species

Brilhante, R. S. N., Caetano, É. P., de Oliveira, J. S., Castelo‐Branco, D. D. S. C. M., Souza, E. R. Y., de Alencar, L. P., Cordeiro, R. D. A., Bandeira, T. D. J. P. G., Sidrim, J. J. C., & Rocha, M. F. G. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.06.001 · Cited by 42 · see citing works

The Elastic Properties of the Cryptococcus neoformans Capsule

Frasés, S., Pontes, B., Nimrichter, L., Rodrigues, M. L., Viana, N. B., & Casadevall, A. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.04.043 · Cited by 42 · see citing works

IFN-γ impairs Trichophyton rubrum proliferation in a murine model of dermatophytosis through the production of IL-1β and reactive oxygen species

Baltazar, L. D. M., Santos, P. C., de Paula, T. P., Rachid, M. A., Cisalpino, P. S., Souza, D. G., & Santos, D. A. (2014) · Medical Mycology · doi:10.1093/mmy/myt011 · Cited by 41 · see citing works

Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model

Souraud, J.-B., Briolant, S., Dormoi, J., Mosnier, J., Savini, H., Baret, E., Amalvict, R., Soulard, R., Rogier, C., & Pradines, B. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-13 · Cited by 36 · see citing works

The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine

Chamilos, G., & Kontoyiannis, D. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235166.16421.e5 · Cited by 30 · see citing works

A New Method for Studying Mechanics of Breathing Using Cathode Ray Oscillograph.

DuBoist, A. B., & Ross, B. B. (1951) · Experimental Biology and Medicine · doi:10.3181/00379727-78-19135 · Cited by 21 · see citing works

The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: A proposal as a therapeutic target and as a study model

Andrade-Pavón, D., Sanchez‐Sandoval, E., Rosales-Acosta, B., Ibarra, J. A., Tamariz, J., Hernández-Rodríguez, C., & Villa‐Tanaca, L. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.004 · Cited by 20 · see citing works

Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: Role of PPARγ receptors

Malekinejad, H., Mehrabi, M., Khoramjouy, M., & Rezaei-Golmisheh, A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.013 · Cited by 17 · see citing works

Beneficial effects of statins on outcomes in pneumonia: a systematic review and meta-analysis.

Hh, C., Tt, T., He, Q., Lj, H., Xl, L., Chen, M., Yang, C., Df, G., & Sp, J. (2014) · PubMed · Cited by 16 · see citing works

Statins Reduce Mortality After Non-severe but Not After Severe Pneumonia: A Systematic Review and Meta-Analysis

Jia, M., Huang, W., Li, L., Xu, Z., & Wu, L. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j34307 · Cited by 13 · see citing works

Is there a role for statins in fungal infections?

Bergman, P. W., & Björkhem-Bergman, L. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.856755 · Cited by 12 · see citing works

Drug Repurposing for the Treatment of Bacterial and Fungal Infections

Miró-Canturri, A., Ayerbe-Algaba, R., & Smani, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00041 · Cited by 210 · see citing works

Statins: a viable candidate for host-directed therapy against infectious diseases

Parihar, S. P., Guler, R., & Brombacher, F. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0094-3 · Cited by 155 · see citing works

Antifungal drugs: New insights in research & development

Nicola, A. M., Albuquerque, P., Paes, H. C., Fernandes, L., Costa, F. F., Kioshima, É. S., Abadio, A. K. R., Bocca, A. L., & Felipe, M. S. S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.008 · Cited by 143 · see citing works

Antifungal effects of statins

Tavakkoli, A., Johnston, T. P., & Sahebkar, A. (2020) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2020.107483 · Cited by 73 · see citing works

Drug repurposing strategies in the development of potential antifungal agents

Zhang, Q., Liu, F., Zeng, M., Mao, Y., Song, Z., Mao, Y., & Song, Z. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11407-7 · Cited by 72 · see citing works

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi

Peyclit, L., Yousfi, H., Rolain, J., & Bittar, F. (2021) · Pharmaceuticals · doi:10.3390/ph14050488 · Cited by 56 · see citing works

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 55 · see citing works

Influenza A Virus as a Predisposing Factor for Cryptococcosis

Oliveira, L. V. N., da Costa, M. C., Magalhães, T. F. F., Bastos, R. W., Santos, P. C., Carneiro, H. C. S., Ribeiro, N. Q., Ferreira, G. F., Ribeiro, L. S., Gonçalves, A. P., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00419 · Cited by 34 · see citing works

Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways

Hetta, ‏. F., Melhem, T., Aljohani, H. M., Salama, A., Ahmed, R., Elfadil, H., Alanazi, F. E., Ramadan, Y. N., Battah, B., Rottura, M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18030364 · Cited by 31 · see citing works

Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii

Carneiro, H. C. S., Bastos, R. W., Ribeiro, N. Q., Gouveia‐Eufrásio, L., da Costa, M. C., Magalhães, T. F. F., Oliveira, L. V. N., da Paixão, T. A., Joffe, L. S., Rodrigues, M. L., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140135 · Cited by 30 · see citing works

Reprogramming of antibiotics to combat antimicrobial resistance

Dubey, K. K., Indu, & Sharma, M. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000168 · Cited by 24 · see citing works

High Efficiency Drug Repurposing Design for New Antifungal Agents

Jong Heon, K. I. M., Chan, K. L., Cheng, L. W., Tell, L. A., Byrne, B. A., Clothier, K. A., & Land, K. M. (2019) · Methods and Protocols · doi:10.3390/mps2020031 · Cited by 24 · see citing works

Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis

de Oliveira Neto, A. S., Souza, I. L. A., Amorim, M. E. S., de Freitas Souza, T., Rocha, V. N., do Couto, R. O., Fabri, R. L., & de Freitas Araújo, M. G. (2021) · Medical Mycology · doi:10.1093/mmy/myaa071 · Cited by 22 · see citing works

Searching for new antifungals for the treatment of cryptococcosis

de Sousa, N. S. O., de Almeida, J. D. R., Frickmann, H., Lacerda, M., & de Souza, J. V. B. (2023) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0121-2023 · Cited by 21 · see citing works

The Antifungal and Synergistic Effect of Bisphosphonates in Cryptococcus

Kane, A., Campbell, L. T., Ky, D., Hibbs, D. E., & Carter, D. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01753-20 · Cited by 21 · see citing works

Novel avenues for identification of new antifungal drugs and current challenges

Jampílek, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2097659 · Cited by 19 · see citing works

Repurposing approach identifies new treatment options for invasive fungal disease

Capoci, I. R. G., Faria, D. R., Sakita, K. M., Rodrigues-Vendramini, F. A. V., Mendonca, P., Becker, T. C. A., Kioshima, É. S., Svidzinski, T. I. E., & Maigret, B. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.019 · Cited by 19 · see citing works

Loading and evaluation of meloxicam and atorvastatin in carrageenan microspherical aerogels particles

Alnaief, M., Obaidat, R., & Mashaqbeh, H. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.90112 · Cited by 18 · see citing works

Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19

Das, R., Kotra, K., Singh, P., Loh, B., Leptihn, S., & Bajpai, U. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00559-8 · Cited by 17 · see citing works

Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis

Ribeiro, N. Q., Santos, A. P. N., Emídio, E. C. P., da Costa, M. C., de Freitas, G. J. C., do Carmo, P. H. F., Silva, M. F., de Brito, C. B., de Souza, D. G., da Paixão, T. A., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.020 · Cited by 17 · see citing works

Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice

de Paula, T. P., Santos, P. C., Arifa, R. D. D. N., Vieira, A. T., Baltazar, L. D. M., Ávila, T. V., Fagundes, C. T., Garcia, Z. M., Lima, R. L., Teixeira, M. M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00764-17 · Cited by 16 · see citing works

Exposure of Aspergillus fumigatus to Atorvastatin Leads to Altered Membrane Permeability and Induction of an Oxidative Stress Response

Ajdidi, A., Sheehan, G., & Kavanagh, K. A. (2020) · Journal of Fungi · doi:10.3390/jof6020042 · Cited by 14 · see citing works

Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses

Gómez-Gaviria, M., Contreras-López, L. M., Aguilera-Domínguez, J. I., & Mora-Montes, H. M. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s466336 · Cited by 10 · see citing works

N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis

Magalhães, T. F. F., da Costa, M. C., Holanda, R. A., Ferreira, G. F., Carvalho, V. S. D., de Freitas, G. J. C., Ribeiro, N. Q., Emídio, E. C. P., do Carmo, P. H. F., de Brito, C. B., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz129 · Cited by 9 · see citing works

Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale

do Carmo, P. H. F., da Costa, M. C., Leocádio, V. A. T., Gouveia‐Eufrásio, L., Emídio, E. C. P., Pimentel, S. P., da Paixão, T. A., Peres, N. T. A., & Santos, D. A. (2022) · Medical Mycology · doi:10.1093/mmy/myac088 · Cited by 9 · see citing works

Biotechnological Production of Statins: Metabolic Aspects and Genetic Approaches

Neto, R. N. M., Gomes, E. D. B., Soares, L. W., Dias, L. R. L., da Silva, L. C. N., & de Miranda, R. D. C. M. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190718165746 · Cited by 8 · see citing works

Antimicrobial and Immunomodulatory Activities of Dried Extracts of Echinacea Purpurea

de Oliveira, B. G., Santos, L. F. F., da Costa, M. C., Bastos, R. W., do Carmo, P. H. F., Santos, D. A., Pianetti, G. A., & César, I. C. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e21026 · Cited by 7 · see citing works

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies

e Silva, D. M., de Souza Lacerda, L., de Souza Andrioli, A., Braz, W. R., Campos, L. M., de Paiva, M. R. B., Pittella, F., Fabri, R. L., & Tavares, G. D. (2025) · Fundamental &amp; Clinical Pharmacology · doi:10.1111/fcp.70046 · Cited by 7 · see citing works

Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review

de Oliveira, E. A. M., Ferreira, G. F., & Lang, K. L. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02824-4 · Cited by 6 · see citing works

Nicotiana benthamiana as a model for studying Cryptococcus–plant interaction

Dornelas, J. C. M., da Costa, M. C., do Carmo, P. H. F., Paixão, V. M., Carvalho, V. S. D., Barreto, L. C., Garcia, Q. S., Bragança, G. P. P., Isaías, R. M. D. S., Brito, J. C. M., et al. (2022) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiac036 · Cited by 6 · see citing works

Proteasome inhibition as a therapeutic target for the fungal pathogen Cryptococcus neoformans

Caza, M., Santos, D. A., Burden, E., Brisland, A., Hu, G., & Kronstad, J. W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01904-23 · Cited by 4 · see citing works

Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil

Fonseca, D. L. D. H., Silva, D. M. W., & Maranhão, F. C. D. A. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01313-1 · Cited by 4 · see citing works

Drug repurposing for fungal infections

Mathuria, A., Ali, N., Kataria, N., & Mani, I. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.04.002 · Cited by 4 · see citing works

Transcriptomic profiling of lung alveolar macrophages reveals distinct contribution of sterol metabolism in macrophage response to Cryptococcus gattii infection

Jeerawattanawart, S., Hansakon, A., Alberts, R., Zhang, Y., & Angkasekwinai, P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333090 · Cited by 3 · see citing works

Off-Label Treatments As Potential Accelerators in the Search for the Ideal Antifungal Treatment Of Cryptococcosis

Alves, V., Araújo, G. R. D. S., & Frasés, S. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0122 · Cited by 3 · see citing works

Inhibition of neutral lipid synthesis by avarols from a marine sponge

Ohshiro, T., Kobayashi, K., Suzuki, A., Yamazaki, H., Uchida, R., Namikoshi, M., & Tomoda, H. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.06.026 · Cited by 3 · see citing works

Drug Repurposing Identifies New Promising Treatment Options for Invasive Fungal Diseases

Serafin, M. B., Bottega, A., Foletto, V. S., da Rosa, T. F., Machado, C. D. S., Coelho, S. S., Marion, S., & Hörner, R. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.08.014 · Cited by 3 · see citing works

Randomized, phase 1/2, double-blind pioglitazone repositioning trial combined with antifungals for the treatment of cryptococcal meningitis – PIO study

Gouveia‐Eufrásio, L., Ribeiro, N. Q., dos Santos, J. R. A., da Costa, M. C., Emídio, E. C. P., de Freitas, G. J. C., do Carmo, P. H. F., Miranda, B. A., de Oliveira, J. C. M. D., Silva, L. M. V., et al. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100745 · Cited by 3 · see citing works

Multifunctionality of statins as antimicrobials

Plotkin, B. J., Borrelli, A., Erbst, M., Zheng, V., Konaklieva, M. I., Schileru, N., & Sigar, I. M. (2022) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2022.11.3.0114 · Cited by 1 · see citing works

Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against Cryptococcus neoformans H99

de Sousa, N. S. O., de Almeida, J. D. R., da Rocha, L. S., Moreira, I. D. M. B., Fernandes, F. D. S., Matsuura, A. B. J., Cruz, K. S., Lima, É. S., de Souza, É. S., Frickmann, H., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14060602 · Cited by 1 · see citing works

A Critical Appraisal of Off-Label Use and Repurposing of Statins for Non-Cardiovascular Indications: A Systematic Mini-Update and Regulatory Analysis

Artner, A., Diler, I., Hankó, B., Sebők, S., & Zelkó, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155436 · Cited by 1 · see citing works

Statin Use is Associated with Reduced Mortality in Mechanically Ventilated Patients: A Retrospective Propensity-Matched Analysis of MIMIC-III Database

Chen, D., Zhang, H., Wang, L., Lin, Q., & Du, J. (2023) · Intensive Care Research · doi:10.1007/s44231-023-00037-4 · Cited by 1 · see citing works

The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial

Saber-Moghaddam, N., Nodeh, M. M., Ghavami, V., Rahimi, H., Azimi, S. A., Seddigh‐Shamsi, M., Kamandi, M., Allahyari, A., Shariatmaghani, S. S., Elyasi, S., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02892-w · Cited by 1 · see citing works

Drug Repurposing Strategies in the Discovery of Antifungal AgentsPreprint

Zhang, Q., Liu, F., Zeng, M., Xin, C., Zhang, J., Mao, Y., & Song, Z. (2021) · Preprints.org · doi:10.20944/preprints202102.0405.v1 · Cited by 1 · see citing works

Statin Use Is Associated With Reduced Mortality On Mechanically Ventilated Patients:A Retrospective Propensity-Matched AnalysisPreprint

Chen, D., Wang, L., Zhang, H., Lin, Q., Tian, R., Xu, J., Miao, C., Huang, Y. C., Ge, F., Kang, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-383754/v1

Statin Use Is Associated With Reduced Mortality On Mechanically Ventilated Patients : A Retrospective Propensity-Matched Analysis Of MIMIC-III DatabasePreprint

Chen, D., Zhang, H., Wang, L., Tian, R., Lin, Q., Xu, J., Miao, C., Ge, F., Kang, M., Zhu, Y., et al. (2021) · Research Square · doi:10.21203/rs.2.24187/v2

Cholesterol and pathogens

Clemente, T. M., & Gilk, S. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00018-3

Statin Use Is Associated With Reduced Mortality On Mechanically Ventilated Patients: A Retrospective Propensity-Matched Analysis Of MIMIC-III DatabasePreprint

Lin, Q., Chen, D., Xu, J., Miao, C., Huang, Y., Wang, L., Ge, F., Kang, M., Tian, R., Zhu, Y., et al. (2020) · Research Square · doi:10.21203/rs.2.24187/v1

Reposicionamento de fármacos para o tratamento de criptococose

de Oliveira, E. A. M. (2022) · doi:10.34019/ufjf/di/2022/00012

Influence of the agrochemical benomyl on Cryptococcus gattii-plant interaction in vitro and in vivo

Dornelas, J. C. M., Paixão, V. M., do Carmo, P. H. F., da Costa, M. C., Gomes, E. C. Q., de Resende, M. A., & Santos, D. A. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01440-9

Deciphering the mechanisms of action of promising defensins to design a new generation of antimicrobials

Kharrat, O. (2025) · doi:10.70675/c47e5b02ze7d4z4d9cz9fd6z03e321b9669f

BindingDB Entry 50007775: Inhibition of neutral lipid synthesis by avarols from a marine sponge.

BindingDB (2021) · UC San Diego · doi:10.7270/q2nk3jc2

Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin

Nasr Esfahani, A., Golestannejad, Z., Khozeimeh, F., Dehghan, P., Maheronnaghsh, M., & Zarei, Z. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1209 · Cited by 28 · see citing works

Astemizole and an analogue promote fungicidal activity of fluconazole againstCryptococcus neoformansvar.grubiiandCryptococcus gattii

Vu, K., & Gelli, A. (2010) · Medical Mycology · doi:10.3109/13693780903081968 · Cited by 28 · see citing works

Synergetic action of atorvastatin and fluconazole against fluconazole-resistant Candida albicans in vitro and in a murine model for intra-abdominal Candidiasis / Ação sinérgica da atorvastatina e fluconazol contra Candida albicans resistente ao fluconazol in vitro e em um modelo murino contra Candidíase intra-abdominal

De Oliveira, M. É., De Lima, W. G., Alves, C. F. B., Herrera, K. M. S., Santos, P. C., De Souza, D. D. G., Dos Santos, M. E. S. M., Ribeiro, R. I. D. M. D. A., Thomé, R. G., Dos Santos, H. B., et al. (2022) · Brazilian Journal of Development · doi:10.34117/bjdv8n5-543 · Cited by 3 · see citing works

High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis

dos Santos, J. R. A., Ribeiro, N. Q., Bastos, R. W., Holanda, R. A., da Silva, L. C., QUEIROZ, E. R., & Santos, D. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-04588-7 · Cited by 17 · see citing works

Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis

dos Santos, J. R. A., Holanda, R. A., Frasés, S., Bravim, M., Araújo, G. R. D. S., Santos, P. C., da Costa, M. C., Ribeiro, M. J. A., Ferreira, G. F., Baltazar, L. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112669 · Cited by 46 · see citing works